ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,208Top JournalHybrid

Thrombosis and Haemostasis

Acronym:th
•
Abbreviation (ISO):THROMB HAEMOSTASIS
•
Identifier (ISSN):0340-6245(Print)/2567-689X(Online)
•
Publisher:Schattauer GmbH
Clarivate IF (2026)
5.2↑ +0.9
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Thrombosis and Haemostasis

WoS Q1
35794.9520184.7320194.3820205.2520216.6820226.72023520244.320255.22026
Annual Impact Factor Metric
Current (2026):5.2
Scopus SJR & RankScopus Q1
1.584
#2,208

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
217

217 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate14%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
152articles/year
32.87% Gold OA•82.48% Original Research

Aims & Scope

Thrombosis and Haemostasis publishes reports on basic, translational and clinical research dedicated to novel results and highest quality in any area of thrombosis and haemostasis, vascular biology and medicine, inflammation and infection, platelet and leukocyte biology, from genetic, molecular & cellular studies, diagnostic, therapeutic & preventative studies to high-level translational and clinical research. The journal provides position and guideline papers, state-of-the-art papers, expert analysis and commentaries, and dedicated theme issues covering recent developments and key topics in the field.

Topics Covered (Recognized by AI)
MedicineInternal MedicineBiologyChemistryBiochemistryPsychologyPsychiatrySurgeryImmunologyGeneticsEndocrinologyPhysicsCardiologyPathologyOrganic Chemistry

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

HEMATOLOGY

Q1
Rank16/103
IndexSCIE
JCRSCIE2026

PERIPHERAL VASCULAR DISEASE

Q1
Rank17/100
IndexSCIE
JCISCIE2026

HEMATOLOGY

Q1
Rank17/103
IndexSCIE
JCISCIE2026

PERIPHERAL VASCULAR DISEASE

Q1
Rank14/100
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.2
Articles / Year122
Total Citations36
2025
IF4.3
Articles / Year242
Total Citations387
2024
IF5
Articles / Year153
Total Citations1,218
2023
IF6.7
Articles / Year170
Total Citations1,697
2022
IF6.681
Articles / Year161
Total Citations1,918

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,208Scopus Q1SCImago Profile
Scopus Coverage:1976-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q1
1.584

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.90

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,595 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,078
3-Year Documents514
Citable Documents424

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate41.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

HematologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 14%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区HEMATOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Thrombosis and Haemostasis (acronym: th, abbr: THROMB HAEMOSTASIS, ISSN: 0340-6245) is a peer-reviewed international scholarly journal in the field of Medicine, published by Schattauer GmbH in Germany since 1976. The periodical holds a Journal Impact Factor (JIF) of 5.20, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.584 (Q1), an H-index of 217.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 152 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,595 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Schattauer GmbH
Publication Language
English
Frequency
Monthly
Founding Year
1976
Indexing & Databases
SCIEScopusPubMed
Editorial Address
SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN, HOLDERLINSTRASSE 3, STUTTGART, GERMANY, D-70174

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 3c850054-95ac-46d7-9f87-e804df887f23
Database Updated: 2026-09-28